Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms.

Strong AL, Ohlstein JF, Jiang Q, Zhang Q, Zheng S, Boue SM, Elliott S, Gimble JM, Burow ME, Wang G, Bunnell BA. Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms. Stem Cell Res Ther. 2014 Aug 28; 5(4):105.

View in: PubMed

subject areas

Adult Stem Cells
Alkaline Phosphatase
Bone Density Conservation Agents
Bone Marrow Cells
Cell Differentiation
Cells, Cultured
Drug Evaluation, Preclinical
Estradiol
Female
Humans
Inhibitory Concentration 50
Isoflavones
Mesenchymal Stem Cells
Osteogenesis
Osteoporosis
Phytoestrogens
Receptors, Estrogen

authors with profiles

Guangdi Wang